IL22 and fatty liver disease: It was also shown that IDO1-deficient mice are protected from obesity, hepatic steatosis, insulin resistance, and chronic inflammation, which is through a shift of tryptophan metabolism from kynurenine pathway to a gut microbiota-mediated production of indole derivative, leading to increased intestinal level of IL-22 and preserved intestinal barrier function [115].